Ritu Baral
Stock Analyst at TD Cowen
(4.98)
# 65
Out of 4,662 analysts
1057
Total ratings
57.6%
Success rate
47.3%
Average return
Main Sectors:
Stocks Rated by Ritu Baral
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OVID Ovid Therapeutics | Maintained: Buy | n/a | $2.83 | - | 25 | Aug 17, 2026 | |
| MIST Milestone Pharmaceuticals | Maintained: Buy | $8 | $1.10 | +627.27% | 36 | Aug 12, 2026 | |
| NGNE Neurogene | Maintained: Buy | n/a | $36.14 | - | 24 | Aug 11, 2026 | |
| VERA Vera Therapeutics | Maintained: Buy | $78 | $31.63 | +146.60% | 26 | Aug 11, 2026 | |
| VTVT vTv Therapeutics | Maintained: Buy | $67 | $30.12 | +122.44% | 4 | Aug 7, 2026 | |
| INSM Insmed | Maintained: Buy | $243 | $123.74 | +96.38% | 73 | Aug 6, 2026 | |
| IRD Opus Genetics | Maintained: Buy | n/a | $3.61 | - | 2 | Aug 6, 2026 | |
| SRPT Sarepta Therapeutics | Rated: Hold | $17 | $18.10 | -6.08% | 104 | Aug 6, 2026 | |
| PRAX Praxis Precision Medicines | Maintained: Buy | $510 | $366.81 | +39.04% | 28 | Aug 6, 2026 | |
| GHRS GH Research | Maintained: Buy | n/a | $29.49 | - | 15 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $37 | $28.24 | +31.02% | 66 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 | $13.45 | +115.61% | 23 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $267 | $156.13 | +71.01% | 17 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $403 | $332.27 | +21.29% | 41 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $482 | $228.65 | +110.80% | 101 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $4.60 | +117.39% | 7 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $644 | $507.56 | +26.88% | 45 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.26 | - | 21 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.46 | - | 9 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $20.20 | +127.72% | 1 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €8.65 | €3.88 | +122.93% | 8 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $12.56 | - | 5 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $32.14 | - | 17 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $10.55 | +99.05% | 18 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $11.99 | -33.28% | 1 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.23 | - | 25 | Nov 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $16.99 | - | 15 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.175 | n/a | 37 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.7281 | n/a | 11 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.99 | n/a | 5 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.07 | n/a | 12 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $52.64 | n/a | 2 | Nov 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $34.91 | n/a | 11 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $57.24 | n/a | 9 | Feb 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $17.14 | n/a | 22 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $52.52 | n/a | 5 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $71.70 | n/a | 37 | May 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $26.49 | n/a | 8 | Jan 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $48.62 | n/a | 17 | Dec 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.001 | n/a | 23 | Oct 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.22 | n/a | 4 | Jul 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $74.13 | n/a | 22 | Apr 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.56 | n/a | 14 | Apr 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $22.08 | n/a | 7 | Apr 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.54 | n/a | 7 | Mar 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.38 | n/a | 6 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $29 | $1.90 | n/a | 2 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $291 → $355 | $209.83 | n/a | 5 | Jan 27, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $1.6 | $14.07 | n/a | 17 | Nov 18, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $3 | $0.0001 | n/a | 7 | Jul 9, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $6 | $2.22 | n/a | 5 | Jun 25, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.23 | n/a | 3 | Jun 18, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $13 | $17.19 | n/a | 1 | Mar 14, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $7.41 | n/a | 1 | Feb 21, 2012 |
Ovid Therapeutics
Aug 17, 2026
Maintained: Buy
Price Target: n/a
Current: $2.83
Upside: -
Milestone Pharmaceuticals
Aug 12, 2026
Maintained: Buy
Price Target: $8
Current: $1.10
Upside: +627.27%
Neurogene
Aug 11, 2026
Maintained: Buy
Price Target: n/a
Current: $36.14
Upside: -
Vera Therapeutics
Aug 11, 2026
Maintained: Buy
Price Target: $78
Current: $31.63
Upside: +146.60%
vTv Therapeutics
Aug 7, 2026
Maintained: Buy
Price Target: $67
Current: $30.12
Upside: +122.44%
Insmed
Aug 6, 2026
Maintained: Buy
Price Target: $243
Current: $123.74
Upside: +96.38%
Opus Genetics
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $3.61
Upside: -
Sarepta Therapeutics
Aug 6, 2026
Rated: Hold
Price Target: $17
Current: $18.10
Upside: -6.08%
Praxis Precision Medicines
Aug 6, 2026
Maintained: Buy
Price Target: $510
Current: $366.81
Upside: +39.04%
GH Research
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $29.49
Upside: -
Aug 5, 2026
Rated: Buy
Price Target: $37
Current: $28.24
Upside: +31.02%
Aug 5, 2026
Maintained: Buy
Price Target: $29
Current: $13.45
Upside: +115.61%
Aug 4, 2026
Maintained: Buy
Price Target: $267
Current: $156.13
Upside: +71.01%
Aug 3, 2026
Maintained: Buy
Price Target: $403
Current: $332.27
Upside: +21.29%
Jul 31, 2026
Rated: Buy
Price Target: $482
Current: $228.65
Upside: +110.80%
Jul 31, 2026
Maintained: Buy
Price Target: $10
Current: $4.60
Upside: +117.39%
Jul 30, 2026
Maintained: Buy
Price Target: $644
Current: $507.56
Upside: +26.88%
Jul 17, 2026
Downgraded: Hold
Price Target: n/a
Current: $7.26
Upside: -
Jul 17, 2026
Maintained: Buy
Price Target: n/a
Current: $6.46
Upside: -
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $20.20
Upside: +127.72%
Jun 8, 2026
Maintained: Buy
Price Target: €8.65
Current: €3.88
Upside: +122.93%
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $12.56
Upside: -
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $32.14
Upside: -
May 12, 2026
Maintained: Buy
Price Target: $21
Current: $10.55
Upside: +99.05%
Apr 13, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $11.99
Upside: -33.28%
Nov 16, 2025
Maintained: Hold
Price Target: n/a
Current: $1.23
Upside: -
Nov 10, 2025
Maintained: Buy
Price Target: n/a
Current: $16.99
Upside: -
Aug 11, 2025
Maintained: Buy
Price Target: n/a
Current: $0.175
Upside: n/a
Aug 11, 2025
Maintained: Buy
Price Target: n/a
Current: $0.7281
Upside: n/a
Apr 11, 2025
Maintained: Hold
Price Target: n/a
Current: $5.99
Upside: n/a
Feb 18, 2025
Maintained: Buy
Price Target: n/a
Current: $1.07
Upside: n/a
Nov 23, 2021
Downgraded: Hold
Price Target: n/a
Current: $52.64
Upside: n/a
Mar 16, 2020
Maintained: Buy
Price Target: n/a
Current: $34.91
Upside: n/a
Feb 27, 2020
Maintained: Hold
Price Target: n/a
Current: $57.24
Upside: n/a
Feb 24, 2020
Maintained: Buy
Price Target: n/a
Current: $17.14
Upside: n/a
Aug 14, 2019
Rated: Buy
Price Target: n/a
Current: $52.52
Upside: n/a
May 8, 2019
Maintained: Hold
Price Target: n/a
Current: $71.70
Upside: n/a
Jan 6, 2019
Maintained: Buy
Price Target: n/a
Current: $26.49
Upside: n/a
Dec 3, 2018
Maintained: Buy
Price Target: n/a
Current: $48.62
Upside: n/a
Oct 12, 2018
Rated: Hold
Price Target: n/a
Current: $0.001
Upside: n/a
Jul 2, 2018
Downgraded: Hold
Price Target: n/a
Current: $4.22
Upside: n/a
Apr 6, 2018
Maintained: Hold
Price Target: n/a
Current: $74.13
Upside: n/a
Apr 6, 2018
Maintained: Hold
Price Target: n/a
Current: $1.56
Upside: n/a
Apr 6, 2018
Maintained: Hold
Price Target: n/a
Current: $22.08
Upside: n/a
Mar 16, 2017
Reiterated: Buy
Price Target: n/a
Current: $4.54
Upside: n/a
Dec 30, 2016
Rated: Hold
Price Target: n/a
Current: $5.38
Upside: n/a
May 15, 2014
Rated: Buy
Price Target: $25 → $29
Current: $1.90
Upside: n/a
Jan 27, 2014
Reiterated: Buy
Price Target: $291 → $355
Current: $209.83
Upside: n/a
Nov 18, 2013
Initiated Coverage: Hold
Price Target: $1.6
Current: $14.07
Upside: n/a
Jul 9, 2012
Reiterated: Buy
Price Target: $6 → $3
Current: $0.0001
Upside: n/a
Jun 25, 2012
Reiterated: Hold
Price Target: $8 → $6
Current: $2.22
Upside: n/a
Jun 18, 2012
Reiterated: Buy
Price Target: $6
Current: $1.23
Upside: n/a
Mar 14, 2012
Upgraded: Buy
Price Target: $13
Current: $17.19
Upside: n/a
Feb 21, 2012
Reiterated: Buy
Price Target: $14
Current: $7.41
Upside: n/a